Justin Leong Resmed Inc (RSMDF) insider trading activity

Justin Leong is Chief Product Officer of RESMED INC. Currently has a direct ownership of 29,028 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on Nov 20, 2025, when has been sold 1,848 shares (ReMed Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29K

6.8% 3M change

33.66% 12M change

Total Value Held $0

Justin Leong Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 20 2025	BUY Grant, award, or other acquisition	-	1,848 Added 5.99%	29,028 ReMed Common Stock
Aug 15 2025	BUY Grant, award, or other acquisition	-	5,462 Added 16.73%	27,180 ReMed Common Stock
Nov 22 2024	SELL Open market or private sale	$1,497,434 $243.09 p/Share	6,160 Reduced 22.1%	21,718 ReMed Common Stock
Aug 15 2024	BUY Grant, award, or other acquisition	-	9,137 Added 24.68%	27,878 ReMed Common Stock
Aug 05 2024	SELL Open market or private sale	$10,419,360 $217.07 p/Share	48,000 Reduced 71.92%	18,741 ReMed Common Stock
Nov 23 2022	BUY Grant, award, or other acquisition	-	6,924 Added 9.4%	66,741 ReMed Common Stock
Nov 22 2022	SELL Open market or private sale	$866,821 $229.5 p/Share	3,777 Reduced 5.94%	59,817 ReMed Common Stock

Nov 22 2022	BUY Exercise of conversion of derivative security	$866,400 $57.76 p/Share	15,000 Added 19.09%	63,594 ReMed Common Stock
Nov 24 2021	SELL Payment of exercise price or tax liability	$341,191 $254.81 p/Share	1,339 Reduced 2.69%	48,391 ReMed Common Stock
Nov 18 2021	BUY Grant, award, or other acquisition	-	638 Added 1.25%	50,495 ReMed Common Stock
Nov 16 2021	BUY Grant, award, or other acquisition	$2,334,569 $254.81 p/Share	9,162 Added 15.52%	49,857 ReMed Common Stock
Aug 19 2021	BUY Grant, award, or other acquisition	-	2,631 Added 6.07%	40,695 ReMed Common Stock
Jan 18 2021	BUY Grant, award, or other acquisition	-	865 Added 2.22%	38,064 ReMed Common Stock
Nov 17 2020	BUY Grant, award, or other acquisition	$2,536,724 $214.74 p/Share	11,813 Added 24.1%	37,199 ReMed Common Stock
Nov 05 2020	SELL Open market or private sale	$1,635,926 $211.36 p/Share	7,740 Reduced 23.37%	25,386 ReMed Common Stock
Nov 05 2020	BUY Exercise of conversion of derivative security	$447,062 $57.76 p/Share	7,740 Added 18.94%	33,126 ReMed Common Stock

Justin Leong

Chief Product Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RSMDF shares.

Notify only if

Value

Insider Trading

Get notified when an Resmed Inc insider buys or sells RSMDF shares.

Notify only if

Operation

Value

Type

News

Receive news related to RESMED INC

Track Activities on RSMDF

Account